SPIDER LAB ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.7% 1.7% 1.7% 1.7% 1.7%  
Bankruptcy risk  5.1% 5.6% 4.2% 3.3% 2.1%  
Credit score (0-100)  43 39 48 53 68  
Credit rating  BBB BBB BBB BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  821 1,085 1,103 1,391 1,379  
EBITDA  248 612 455 682 699  
EBIT  248 612 455 682 699  
Pre-tax profit (PTP)  221.9 604.3 194.2 669.8 904.5  
Net earnings  166.7 461.6 141.0 519.8 695.7  
Pre-tax profit without non-rec. items  222 604 194 670 905  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  710 1,058 1,085 1,487 2,009  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  985 1,380 1,417 1,802 2,378  

Net Debt  -820 -1,153 -1,388 -1,651 -2,180  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  821 1,085 1,103 1,391 1,379  
Gross profit growth  1.1% 32.2% 1.6% 26.1% -0.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  985 1,380 1,417 1,802 2,378  
Balance sheet change%  -30.0% 40.0% 2.7% 27.1% 32.0%  
Added value  247.6 612.4 454.6 681.9 699.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  30.2% 56.4% 41.2% 49.0% 50.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.0% 51.8% 35.0% 42.4% 43.8%  
ROI %  25.1% 69.3% 45.7% 53.0% 52.4%  
ROE %  17.7% 52.2% 13.2% 40.4% 39.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  72.0% 76.7% 76.5% 82.5% 84.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -331.0% -188.2% -305.4% -242.1% -311.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  174.1% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.6 4.3 4.3 5.7 6.0  
Current Ratio  3.6 4.3 4.3 5.7 6.0  
Cash and cash equivalent  819.5 1,152.6 1,388.2 1,650.9 2,179.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  709.5 1,058.1 184.3 60.2 -207.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  248 612 455 682 699  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  248 612 455 682 699  
EBIT / employee  248 612 455 682 699  
Net earnings / employee  167 462 141 520 696